Literature DB >> 7847566

Recipient's age does not adversely affect pregnancy outcome after oocyte donation.

R S Legro1, I L Wong, R J Paulson, R A Lobo, M V Sauer.   

Abstract

OBJECTIVE: Our purpose was to examine the effect of the recipient's age on pregnancy and miscarriage rates after oocyte donation. STUDY
DESIGN: A retrospective analysis of 307 consecutively performed donor oocyte cycles was undertaken. Recipients were divided into two groups: younger group < or = 42 years old (165 cycles) versus older group > 42 years old (145 cycles). Pregnancy outcomes between groups were compared. Confounding variables such as donor and cycle characteristics, recipient characteristics, and male parameters were also examined.
RESULTS: Both groups had the same incidence (6%) of failed fertilization cycles. At least one embryo was transferred in the remaining 286 cycles. Ongoing or delivered pregnancy rates per embryo transfer were similar for younger and older groups (30.2% vs 30.6%). Differences in miscarriage rates were not statistically significant (9.8% vs 16.3%). There were no differences in the cycle parameters related to donor age, number of oocytes aspirated, number of oocytes fertilized, and number of embryos transferred. Donor sperm was more frequently utilized in the older group (19 vs 4 cycles, p = 0.0002). In the remaining cycles male partners of older recipients were significantly older (37.9 +/- 0.5 years vs 43.9 +/- 0.6 years, p < 0.0001), but there were no differences in semen parameters or fertilization rates. Older recipients were more likely to be parous but also to have experienced a previous miscarriage.
CONCLUSION: Recipient age does not adversely affect cycle outcome with donor oocytes. This implies that aging of the uterus is not of clinical significance to patients electing this method of infertility treatment.

Entities:  

Mesh:

Year:  1995        PMID: 7847566     DOI: 10.1016/0002-9378(95)90091-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Quality of embryos transferred and progesterone levels are the most important predictors of live birth after fresh embryo transfer: a retrospective cohort study.

Authors:  Qianfang Cai; Fei Wan; Dina Appleby; Linli Hu; Hanwang Zhang
Journal:  J Assist Reprod Genet       Date:  2013-11-08       Impact factor: 3.412

2.  Predictors of twin live birth following cryopreserved double embryo transfer on day 3.

Authors:  Daniel J Kaser; Stacey A Missmer; Katharine F Correia; S Temel Ceyhan; Mark D Hornstein; Catherine Racowsky
Journal:  J Assist Reprod Genet       Date:  2013-07-04       Impact factor: 3.412

Review 3.  Distributive justice in the allocation of donor oocytes.

Authors:  G Pennings
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

4.  Contribution of male age to outcomes in assisted reproductive technologies.

Authors:  Brian W Whitcomb; Renée Turzanski-Fortner; Kevin S Richter; Simon Kipersztok; Robert J Stillman; Michael J Levy; Eric D Levens
Journal:  Fertil Steril       Date:  2010-07-21       Impact factor: 7.329

5.  In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause?

Authors:  Devini Ameratunga; Gareth Weston; Tiki Osianlis; James Catt; Beverley Vollenhoven
Journal:  J Assist Reprod Genet       Date:  2009-10-22       Impact factor: 3.412

6.  Ovarian reserve may be compromised after adnexal surgery: Are we sufficiently fertility- focused in our surgical training?

Authors:  G S Kalra; S Campbell; G Nargund
Journal:  Facts Views Vis Obgyn       Date:  2016-06-27

7.  Using Bonferroni, BIC and AIC to assess evidence for alternative biological pathways: covariate selection for the multilevel Embryo-Uterus model.

Authors:  Christos Stylianou; Andrew Pickles; Stephen A Roberts
Journal:  BMC Med Res Methodol       Date:  2013-06-06       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.